SCHEMBL6989879

SCHEMBL6989879

NCCOCc1noc2ccccc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.55
CA12 O43570 1/20 0.55
CA1 P00915 1/20 0.55
CA2 P00918 1/20 0.55
CA3 P07451 1/20 0.55
CA4 P22748 1/20 0.55
CA6 P23280 1/20 0.55
MAOB P27338 1/20 0.55
CA5A P35218 1/20 0.55
CA7 P43166 1/20 0.55
CA9 Q16790 1/20 0.55
CA13 Q8N1Q1 1/20 0.55
CA14 Q9ULX7 1/20 0.55
CA5B Q9Y2D0 1/20 0.55
SMN1; SMN2 Q16637 5/20 0.50
CYP3A4 P08684 1/20 0.50
BLM P54132 1/20 0.50
FAAH O00519 1/20 0.40
MGLL Q99685 1/20 0.40
GAA P10253 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31061939 0.78 LMNA (0.59) LMNACA12CA1CA2CA3
SCHEMBL12767421 0.78 LMNA (0.59) LMNACA12CA1CA2CA3
SCHEMBL8203805 0.77 CA12 (0.35) LMNACA12CA1CA2CA3
SCHEMBL2372821 0.77 LMNA (0.62) LMNACA12CA1CA2CA3
SCHEMBL6990274 0.75 FAAH (0.55) LMNACA12CA1CA2CA3
SCHEMBL6989239 0.74 KCNA5 (0.42) LMNACA12CA1CA2CA3
SCHEMBL5618341 0.73 FAAH (0.65) LMNACA12CA1CA2CA3
SCHEMBL1759493 0.73 LMNA (0.50) LMNACA12CA1CA2CA3
SCHEMBL2411271 0.73 LMNA (0.54) LMNACA12CA1CA2CA3
SCHEMBL6989247 0.73 CA12 (0.32) LMNACA12CA1CA2CA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0779281-B1 ISOXAZOLES SANKYO CO (JP) 2003-10-29 EP claimed
EP-0779281-A1 ISOXAZOLES SANKYO COMPANY LIMITED (JP) 1997-06-18 EP claimed
EP-0779281-B1 ISOXAZOLES SANKYO CO (JP) 2003-10-29 EP disclosed
US-6096771-A ISOXAZOLE DERIVATIVES EXHIBITING EXCELLENT TYPE B AND TYPE A MONOAMINE OXIDASE INHIBITORY ACTIVITIES, THEREFORE USEFUL FOR PREVENTING PARKINSON'S DISEASE, DEPRESSION AND ALZHEIMER'S DISEASE SANKYO COMPANY, LIMITED (JP) 2000-08-01 US disclosed
US-5965591-A MONOAMINE OXIDASE INHIBITOR; FOR PROPHYLAXIS AND TREATING PARKINSON'S DISEASE, DEPRESSION AND ALZHEIMER'S DISEASE SANKYO COMPANY, LIMITED (JP) 1999-10-12 US disclosed
EP-0779281-A1 ISOXAZOLES SANKYO COMPANY LIMITED (JP) 1997-06-18 EP disclosed